SXTP
60 Degrees Pharmaceuticals, Inc.
$1.55
-0.07 (-4.32%)
At close · Jul 8
Market Cap
$4.15M
Shares
2,659,288
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Geoffrey Dow | CEO | $727,750 |
| Kristen Landon | — | $311,791 |
| Tyrone Miller | CFO | $283,250 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Kristen Landon | — | $470,862 |
| Geoffrey Dow | CEO | $323,425 |
| Tyrone Miller | CFO | $284,525 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Tyrone Miller | CFO | $135,632 |
| Geoffrey Dow | CEO | $125,555 |
| Kristen Landon | — | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Eric Francois | member of the Board | Appointed | 2026-05-18 |